Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

AURORA Study-A Transformative Approach Utilizing Behavioral Economics, Education, and Data Science to Support Patients Initiating PrEP With Retention-in-care and Medication Persistence

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patients in the study will receive current standard care for HIV prevention and be offered enrollment in the digital health companion program. Goal of the study is to evaluate medication adherence and persistence in patients receiving CAB-LA vs oral PrEP and who engage with a digital health companion program.

Who May Be Eligible (Plain English)

Who May Qualify: - Initiation of or current user of PrEP with CAB-LA, daily FTC/TDF, or daily FTC/TAF prescribed in accordance with the WVHR standard of care practices (based practices on CDC PrEP 2021 Clinical Practice Guidelines) by a licensed HCP - PrEP dispensed by WVHR pharmacy - Access to a smart phone Who Should NOT Join This Trial: - Receiving HIV PrEP care outside of WVHR - Positive HIV diagnosis - Contraindication to oral or injectable PrEP therapy - Receiving oral bridging therapy prior to injectable PrEP therapy Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Initiation of or current user of PrEP with CAB-LA, daily FTC/TDF, or daily FTC/TAF prescribed in accordance with the WVHR standard of care practices (based practices on CDC PrEP 2021 Clinical Practice Guidelines) by a licensed HCP * PrEP dispensed by WVHR pharmacy * Access to a smart phone Exclusion Criteria: * Receiving HIV PrEP care outside of WVHR * Positive HIV diagnosis * Contraindication to oral or injectable PrEP therapy * Receiving oral bridging therapy prior to injectable PrEP therapy

Treatments Being Tested

BEHAVIORAL

Digital Health Companion (mobile App)

Participants will complete education modules, health literacy evaluations, and PRO assessments in the Digital Health Companion.

Locations (1)

West Virginia Health Right
Charleston, West Virginia, United States